Amarin PLC Other Current Assets Over Time
| AMRN Stock | USD 0.49 0.01 2.00% |
With this module, investors can use any or all of fundamental ratio historical patterns as a complementary method for asset selection as well as a tool for deciding entry and exit points. Many technical investors use fundamentals to limit their universe of possible portfolio assets.
Check out Amarin PLC Performance and Amarin PLC Correlation. Amarin |
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Amarin PLC. If investors know Amarin will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Amarin PLC listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.94) | Earnings Share (0.10) | Revenue Per Share 0.588 | Quarterly Revenue Growth (0.36) | Return On Assets (0.03) |
The market value of Amarin PLC is measured differently than its book value, which is the value of Amarin that is recorded on the company's balance sheet. Investors also form their own opinion of Amarin PLC's value that differs from its market value or its book value, called intrinsic value, which is Amarin PLC's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Amarin PLC's market value can be influenced by many factors that don't directly affect Amarin PLC's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Amarin PLC's value and its price as these two are different measures arrived at by different means. Investors typically determine if Amarin PLC is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Amarin PLC's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Cross Equities Other Current Assets Analysis
Compare Amarin PLC and related stocks such as Scilex Holding, Biogen Inc, and Gilead Sciences Other Current Assets Over Time
Select Fundamental| 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| SCLXW | 3.3 M | 3.3 M | 3.3 M | 3.3 M | 3.3 M | 3.3 M | 3.3 M | 3.3 M | 3.3 M | 3.3 M | 3.3 M | 1.8 M | 4.8 M | 4 M | 3.9 M |
| BIIB | 1.3 M | 2.1 B | 404.4 M | 478.8 M | 730.8 M | 1.2 B | 1.4 B | 1.5 B | 1.2 B | 1.2 B | 881.1 M | 740.8 M | 1.4 B | 1.2 B | 1.2 B |
| GILD | 100 K | 10 B | 797.7 M | 91.9 M | 472 M | 506 M | 1.1 B | 1.7 B | 1.6 B | 1.4 B | 2 B | 2.1 B | 1.8 B | 2.4 B | 1.3 B |
| AZN | 753 M | 9.8 B | 8.5 B | 8.5 B | 7.7 B | 7.1 B | 5.1 B | 5.7 B | 7.1 B | 971 M | 1.9 B | 4.8 B | 4.4 B | 5.4 B | 5.3 B |
| SNY | 424 M | 2.4 B | 481 M | 404 M | 515 M | 6.2 B | 6.9 B | 503 M | 701 M | 1 B | 4 B | 4.3 B | 4 B | 3.9 B | 2.2 B |
| NVS | 2.4 B | 706 M | 3.1 B | 3.4 B | 2.5 B | 3 B | 697 M | 756 M | 1.6 B | 2.7 B | 2.9 B | 2.8 B | 2.9 B | 2 B | 2.3 B |
| GSK | 1.6 B | 6.4 B | 5.5 B | 5.7 B | 6 B | 6 B | 6.6 B | 6.4 B | 7.5 B | 1.6 B | 1.9 B | 1.7 B | 1.4 B | 1.6 B | 1.5 B |
| MRK | 58.8 M | 3.7 B | 4.5 B | 4.8 B | 5.3 B | 5.2 B | 4.4 B | 4.3 B | 4.5 B | 4.3 B | 6.9 B | 7 B | 7.2 B | 8.4 B | 8.8 B |
| BMY | 377 M | 1.5 B | 3.1 B | 10.5 B | 4.1 B | 2.5 B | 2.7 B | 576 M | 1.1 B | 2 B | 5.6 B | 1.3 B | 1.7 B | 1.6 B | 2 B |
| AMGN | 600 K | 22.2 B | 1.9 B | 2.2 B | 2.5 B | 1.7 B | 2 B | 1.7 B | 1.8 B | 1.9 B | 2.1 B | 2.4 B | 2.4 B | 1.9 B | 2.7 B |
| ABBV | 4 B | 2 B | 2 B | 2 B | 2.3 B | 1.5 B | 3.6 B | 4.7 B | 1.9 B | 2.4 B | 3.6 B | 5 B | 4.4 B | 4.9 B | 3.5 B |
| JNJ | 246.4 M | 5.2 B | 6.2 B | 7.6 B | 7.1 B | 3 B | 3.3 B | 2.5 B | 3.6 B | 2.5 B | 3.1 B | 3.7 B | 8.7 B | 4.5 B | 3.5 B |
Amarin PLC and related stocks such as Scilex Holding, Biogen Inc, and Gilead Sciences Other Current Assets description
Assets expected to be converted into cash, sold, or consumed either in one year or in the operating cycle, which are not included under standard current asset categories.My Equities
My Current Equities and Potential Positions
| Amarin PLC | AMRN |
Specialization | Health Care, Pharmaceuticals, Biotechnology & Life Sciences |
| Location | Ireland |
| Exchange | NASDAQ Exchange |
USD 0.49
Check out Amarin PLC Performance and Amarin PLC Correlation. To learn how to invest in Amarin Stock, please use our How to Invest in Amarin PLC guide.You can also try the Earnings Calls module to check upcoming earnings announcements updated hourly across public exchanges.
Amarin PLC technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.